Streetbeat News

Products Services

DYN

Dyne Therapeutics has released new clinical data from its Phase 1/2 DELIVER trial of DYNE-251, showing positive results in patients with Duchenne Muscular Dystrophy. The company plans to initiate registrational cohorts and aims for a registration update by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:32 am

EMBC

Embecta has received FDA 510(K) clearance for its new disposable insulin delivery system, designed for adults with diabetes. The system features a tubeless patch pump with a 300-unit insulin reservoir, developed with input from type 2 diabetes patients and healthcare providers.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:31 am

COMM

IDGT

NOK

SIXG

Nokia has partnered with CommScope's RUCKUS Networks to develop integrated fiber and Wi-Fi solutions for various industries. This collaboration aims to enhance connectivity and reduce costs. Nokia's shares are trading lower premarket.

Portfolio Pulse from Lekha Gupta

September 03, 2024 | 10:17 am

BMWYY

TM

TSLA

BMW is recalling over 140,000 Mini Cooper SE electric vehicles globally due to battery overheating risks, with no reported accidents or injuries. This recall is part of a broader trend of safety concerns for BMW, which has recently recalled other vehicles for similar issues. BMW is also working with Toyota to develop fuel cell vehicles.

Portfolio Pulse from Benzinga Neuro

September 03, 2024 | 10:11 am

LNZA

LanzaTech Global has signed a master license agreement with SEKISUI CHEMICAL to develop multiple commercial-scale waste-to-ethanol plants across Japan. SEKISUI will build facilities using LanzaTech's technology and services.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:04 am

RMTI

Rockwell Medical has entered a distribution agreement with Nipro Medical to supply hemodialysis concentrates globally, excluding the US. The agreement is for two years with a $5 million minimum purchase in the first year.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 10:02 am

PFE

VALN

Valneva and Pfizer have announced new data from their Phase 2 study of the Lyme disease vaccine candidate, VLA15. The study shows that the immune response and safety profile after a second booster dose are consistent with previous results, supporting the benefit of booster vaccinations.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 9:39 am

AVGO

MRVL

Nancy Pelosi's purchase of Broadcom call options has drawn attention as the stock shows signs of a bullish breakout. Broadcom's technical chart suggests a potential bullish reversal, and the company is set to announce its third-quarter results soon. Analysts are optimistic about Broadcom's performance, especially given its AI exposure.

Portfolio Pulse from Shanthi Rexaline

September 03, 2024 | 9:24 am

TSLA

Tesla Inc. has launched the 'Actually Smart Summon' feature for its electric vehicles equipped with full self-driving technology. This feature allows users to summon their Tesla cars using their phones, marking a significant update after previous delays.

Portfolio Pulse from Anan Ashraf

September 03, 2024 | 8:44 am

AMD

NVDA

Nvidia is expanding its offerings beyond AI chips to include software, data-center services, and networking technology, aiming to become a one-stop solution for data center clients. This strategy could help Nvidia maintain its dominant market position against competitors like AMD.

Portfolio Pulse from Shanthi Rexaline

September 03, 2024 | 8:30 am